Peetz Christopher — SEC insider filings

SEC reporting owner CIK 1614740. 48 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 48 filings on record, filed 2020-11-12 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mirum Pharmaceuticals, Inc. (MIRM)CHIEF EXECUTIVE OFFICER, Director403 legs · 12,000 sh · $194,28033 legs · 380,280 sh · $27,570,76658
ALPINE IMMUNE SCIENCES, INC. (ALPN)Director71 leg · 1,900 sh · $19,3231 leg · 1,900 sh · $19,32312
Arcutis Biotherapeutics, Inc. (ARQT)Director1——3

Insider filings — Peetz Christopher

FiledFormIssuerReported transactionsSource
2026-11-044Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 20,000 @ $2.94 · Sale (S): 20,000 @ $90 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-10-064Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 5,305 @ $19.19 · Option exercise (M): 6,892 @ $15.87 · Option exercise (M): 5,305 (derivative) @ $0 · Option exercise (M): 6,892 (derivative) @ $0EDGAR
2026-09-034Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 30,000 @ $2.94 · Sale (S): 8,312 @ $98.08 · Sale (S): 21,688 @ $98.91 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2026-08-114Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 20,000 @ $2.94 · Sale (S): 11,683 @ $98.51 · Sale (S): 6,017 @ $99.25 · Sale (S): 2,300 @ $100.14 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-07-174Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 4,315 @ $0 · Grant/award (A): 21,486 (derivative) @ $0 · Grant/award (A): 13,010 (derivative) @ $0EDGAR
2026-07-084Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 20,000 @ $2.94 · Sale (S): 12,134 @ $121.65 · Sale (S): 4,181 @ $122.34 · Sale (S): 1,975 @ $123.74 · Sale (S): 1,710 @ $124.79 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-06-024Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 30,000 @ $2.94 · Sale (S): 2,602 @ $94.64 · Sale (S): 16,595 @ $95.34 · Sale (S): 6,926 @ $96.15 · Sale (S): 1,973 @ $97.56 · Sale (S): 1,021 @ $98.20 · +2 moreEDGAR
2026-03-174Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 25,000 · Option exercise (M): 50,000 · Sale (S): 40,985 @ $91.98 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2026-02-034Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 9,108 @ $103.30EDGAR
2026-01-304Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 67,000 (derivative) @ $0 · Grant/award (A): 43,500 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2026-01-274Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 12,500 · Sale (S): 6,831 @ $96.19 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2026-01-234Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 12,797 · Sale (S): 7,098 @ $93.33 · Option exercise (M): 12,797 (derivative) @ $0EDGAR
2026-01-024Mirum Pharmaceuticals, Inc. (MIRM)Gift (G): 21,070 @ $0EDGAR
2025-11-204Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 19,133 @ $19.24 · Option exercise (M): 19,133 (derivative) @ $0EDGAR
2025-08-124Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 40,000 @ $2.94 · Sale (S): 40,000 @ $62 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2025-08-084Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 40,000 @ $2.94 · Sale (S): 40,000 @ $55.25 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2025-03-184Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 50,000 · Sale (S): 27,279 @ $44.21 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2025-03-044Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 40,000 @ $2.94 · Sale (S): 19,392 @ $46.61 · Sale (S): 20,608 @ $47.19 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2025-02-044Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 9,102 @ $48.22EDGAR
2025-01-274Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 12,500 · Sale (S): 6,837 @ $47.92 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2025-01-234Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 153,550 (derivative) @ $0 · Grant/award (A): 38,390 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2025-01-084Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 7,489 @ $42.82EDGAR
2024-11-144Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 65 @ $21.05EDGAR
2024-07-244Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 34,013 @ $2.94 · Option exercise (M): 34,013 (derivative) @ $0EDGAR
2024-05-204ALPINE IMMUNE SCIENCES, INC. (ALPN)Disposition to issuer (D): 1,900 · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +2 moreEDGAR
2024-05-164Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 817 @ $21.05EDGAR
2024-03-184Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 5,159 @ $20.62EDGAR
2024-02-054Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 6,013 @ $26.19EDGAR
2024-01-254Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0EDGAR
2024-01-094Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 5,209 @ $28.03EDGAR
2024-01-044ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-07-054Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 5,498 @ $25.65EDGAR
2023-05-194Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 1,256 @ $16.92EDGAR
2023-02-024Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 50,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2023-01-054ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-11-144Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 49 @ $17.05EDGAR
2022-05-124Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 1,500 @ $13.57EDGAR
2022-01-074Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 40,000 @ $0 · Grant/award (A): 240,000 (derivative) @ $0EDGAR
2022-01-044ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-11-294Mirum Pharmaceuticals, Inc. (MIRM)Purchase (P): 7,000 @ $14.40EDGAR
2021-10-014Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 21,875 @ $0 · Sale (S): 3,672 @ $19.26EDGAR
2021-09-274/AALPINE IMMUNE SCIENCES, INC. (ALPN)Purchase (P): 1,900 @ $10.17EDGAR
2021-09-244ALPINE IMMUNE SCIENCES, INC. (ALPN)Sale (S): 1,900 @ $10.17EDGAR
2021-05-124Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 1,453 @ $14.62EDGAR
2021-01-114Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 175,000 (derivative) @ $0EDGAR
2021-01-054ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 7,650 (derivative) @ $0EDGAR
2020-12-284Mirum Pharmaceuticals, Inc. (MIRM)Purchase (P): 3,000 @ $18.76 · Purchase (P): 2,000 @ $18.60EDGAR
2020-11-124Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 1,371 @ $15.27EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1614740 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs